Rongxue Wen

Rongxue Wen · Chief Product Officer · China

My product responsibility widened; the boundaries around it remained important.

Chief Product Officer

Neravelle Assurance

Sector
Insurance product propositions and portfolio development
Ownership
Private financial holding company 61%; long-term investors 39%
Company scale
CNY 26 billion company gross written premium in 2025
Employees
6400 company employees at October 2026
Geography
Shanghai headquarters and eight regional offices in China
Reporting to
Chief Executive Officer
Team
172 product colleagues through seven direct reports at October 2026
Financial scope
CNY 94 million delegated 2026 function expense; underwriting, actuarial pricing, claims decisions and legal approvals remain separately accountable

Mandate

Make base benefits, optional elements and proposed product changes distinguishable in the proposition presented for consideration.

Outcomes

  • Separated the physical-damage base from the optional income element after 78 of 120 owners misinterpreted the 2023 prototype.
  • Supported CNY 12 million development and retained 19 unresolved interpretations in a different 100-person exercise, delaying the proposed launch.
  • Distinguished 24 benefit-limit changes from 12 presentation revisions in the 2025 proposed-renewal comparison.

Decisions in context

The CPO appointment made me responsible for the coherence of the product account across a wider range. Coherence could not mean using the same reassuring description when the underlying propositions differed. The small-shop review required an option to remain visibly optional even when the package name made a single story attractive. The renewal comparison required a change in benefit limits to remain different from a change in presentation. Those decisions belonged in an executive explanation alongside their cost and remaining uncertainty. My delegated expense supported product development and research, not authority over all company premium or every claims decision. I began presenting to the board in July 2019 without taking a statutory seat. The chronology records product choices and bounded interpretation findings; it does not convert them into live-policy approvals, sales results or a claim that the function settled every specialised question surrounding the proposition.

Reason for the move

Promoted from portfolio leadership into the enterprise product remit; current role.

Vice-president of product portfolios

Neravelle Assurance

Sector
Insurance product portfolios and service propositions
Ownership
Privately held insurance company
Company scale
CNY 18 billion company gross written premium in 2018
Employees
4900 company employees in 2018
Geography
Shanghai-led portfolio organisation with regional distribution and service relationships
Reporting to
Executive responsible for insurance operations
Team
106 portfolio colleagues through six direct reports in 2018
Financial scope
CNY 58 million annual product-portfolio expense in 2018; pricing, service contracts and claim settlements retained their own approvals

Mandate

Explain the relationships among benefits, limits and service arrangements without enlarging the promises the product account supports.

Outcomes

  • Supported CNY 3.8 million travel-illustration redevelopment after readers confused aggregate and per-item limits in 2012.
  • Separated a home call-out arrangement from an assumption of all repair costs being included in 2018.
  • Funded CNY 8.6 million assistance-explanation work and retained 26 unresolved interpretations in a 120-reader retest.

Decisions in context

Portfolio leadership brought together propositions whose terms were individually stated but not always understood in relationship. The travel illustration showed how a prominent aggregate could eclipse a smaller per-item cap. The assistance review showed how a service message could become an expectation of reimbursement. I wanted the product account to reveal those relationships before a reader relied on the broader interpretation. The work required coordination with specialists rather than a belief that better copy alone could settle an insurance proposition. I accepted fuller explanations and the continued uncertainty shown by the exercises. The expense and team described for 2018 belonged to the portfolio function, while gross written premium described the company. This period prepared me to consider how a product family is understood across different channels, including the risk that one familiar phrase can conceal different benefits, costs or conditions within that family.

Reason for the move

Promoted to CPO with a wider remit for product propositions and their executive explanation.

Product Director

Neravelle Assurance

Sector
Insurance product development and explanatory material
Ownership
Private insurer
Company scale
CNY 8.6 billion company gross written premium in 2011
Employees
3100 company employees in 2011
Geography
China-based product organisation headquartered in Shanghai
Reporting to
Head of product and distribution development
Team
52 product colleagues through four direct reports in 2011
Financial scope
CNY 22 million annual product-function expense in 2011; no independent authority to price all business or determine claims

Mandate

Develop product propositions whose shorter accounts preserved the relationships among their stated conditions.

Outcomes

  • Brought the waiting-period correction from earlier product management into reviews of the opening product explanation.
  • Required product discussions to distinguish the presence of a qualification from evidence that readers understood it.
  • Expanded coordination among product, distribution and specialist colleagues before taking the portfolio remit.

Decisions in context

Joining Neravelle changed the breadth of the product questions I had to coordinate. I could bring experience of a summary that had misled readers in an exercise, but could not assume that every later misunderstanding had the same cause. The relevant condition might concern an option, a monetary limit or a service arrangement. I needed colleagues to describe the proposition precisely before deciding what the shorter account should emphasise. The director role gave me a larger team and expense than product management, while leaving underwriting, pricing and claims authority distinct. I became interested in how an explanation travelled from a product meeting into a distribution conversation. A qualification could be present in the source material and still lose its relationship to the headline by the time someone encountered the offer. That observation prepared the wider portfolio work without implying that the product office should take over each specialist’s conclusion.

Reason for the move

Promoted to portfolio vice-president as responsibility widened across product families.

Product Manager

Calvren Insurance

Sector
Insurance product management and customer explanations
Ownership
Privately owned insurance business
Company scale
CNY 4.8 billion company gross written premium in 2004
Employees
2100 company employees in 2004
Geography
China-based product team supporting insurance distribution colleagues
Reporting to
Head of product management
Team
24 product colleagues through three direct reports in 2004
Financial scope
CNY 7.2 million annual product expense in 2004; underwriting commitments and legal interpretation separately authorised

Mandate

Prepare product summaries that retained conditions material to the reader’s understanding of the proposition.

Outcomes

  • Owned the 2003 immediate-protection wording that obscured a 30-day illness waiting period in an invented scenario.
  • Withdrew the description after 22 of 60 readers interpreted the scenario as illness protection from day one.
  • Supported CNY 1.6 million revision and retained 9 unresolved interpretations in a separate 54-reader exercise.

Decisions in context

The product-manager appointment made my approval consequential for descriptions other colleagues would use. The waiting-period case exposed a weakness in how I exercised that responsibility. I had treated the presence of a qualification as sufficient support for a broad immediate-protection headline. Lanqiu Zhen showed that the main account was producing an interpretation the invented condition did not support. I withdrew the wording and accepted the cost of revising material already built around it. The later exercise did not settle every reader’s understanding, and those limits belonged in the result. This was a correction to my product explanation, not a decision about an actual person’s policy or claim. The experience made me more attentive to the order and prominence of the account before I moved into the director role. It also gave me an example of why scrutiny must be able to reach the person who authorised the earlier description.

Reason for the move

Joined Neravelle to lead product development across a broader range of insurance propositions.

Insurance Analyst

Calvren Insurance

Sector
Insurance product analysis
Ownership
Private insurance business
Company scale
CNY 1.2 billion company gross written premium in 1996
Employees
850 company employees in 1996
Geography
China; analytical support for product and distribution teams
Reporting to
Product analysis supervisor
Team
Individual analyst within a ten-person analysis group
Financial scope
No independent expenditure delegation, line management or underwriting authority

Mandate

Help colleagues examine the relationship between stated product conditions and the summaries used to explain them.

Outcomes

  • Learned to distinguish company premium context from a product analyst’s actual remit.
  • Supported comparisons of product conditions under supervision without approving coverage or customer advice.
  • Developed an interest in how a shorter description changes the relationship among benefits and limitations.

Decisions in context

I started work in August 1990 after completing applied mathematics in June. The analysis group gave me a practical reason to look beyond a correctly copied number. A limit needed the object to which it applied; a period needed the event from which it was measured. My task was to help organise those relationships for colleagues, with supervisors holding approval and spending responsibilities. I did not manage the ten-person group or possess the authority of my later CPO appointment. The historical company scale describes the institution in which the work occurred. This first role explains how I became interested in the product explanation, but it should not make the later summary error seem impossible. Familiarity with conditions can itself make an author assume that another reader will supply the same missing relationship. The career developed partly through learning when that assumption was wrong.

Reason for the move

Promoted into product management after developing insurance-analysis experience.

What I am looking for next

I would like to contribute to an insurance board’s examination of the proposition a customer is being asked to understand. A product family may need a clearer account of base benefits and options, or a renewal programme may need to distinguish altered limits from layout changes. I could bring experience of making those questions concrete, including a summary I had to withdraw. I would expect underwriting, actuarial, claims, legal and financial perspectives to remain part of the collective discussion rather than be replaced by the product view.

This would be a first statutory appointment, requiring preparation beyond executive presentations. Twenty-six annual days would be an initial indication subject to employer agreement and the actual demands, including induction and exceptional matters. Relevant insurance, distribution, supplier and personal relationships would need assessment. I would seek a setting where the board wants to understand the customer’s proposition without expecting a non-executive to run product development. The fictional chronology can expose the reasoning for examination; verified experience and the intended institution’s own assessment would determine whether a real appointment is appropriate.